{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:15:10Z","timestamp":1770747310230,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ando.2011.04.003","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T17:03:34Z","timestamp":1308503014000},"page":"244-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Exenatide improves weight loss insulin sensitivity and \u03b2-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy"],"prefix":"10.1016","volume":"72","author":[{"given":"P.","family":"Oriot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Selvais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buysschaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"de la Tribonni\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2011.04.003_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.diabet.2010.03.009","article-title":"One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice","volume":"36","author":"Buysschaert","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ando.2011.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Data collection on adverse events of anti-HIV drugs (DAD) study. Incidence and risk factors for new-onset diabetes in HIV-infected patients","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2011.04.003_bib0015","first-page":"531","article-title":"Les lipodystrophies secondaires aux traitements antir\u00e9troviraux de l\u2019infection par le VIH","volume":"22","author":"Capeau","year":"2006","journal-title":"Med Sci"},{"key":"10.1016\/j.ando.2011.04.003_bib0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ando.2011.04.003_bib0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/135965350701200809","article-title":"A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study","volume":"12","author":"Kim","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ando.2011.04.003_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.aids.0000206503.01536.11","article-title":"Altered hepatic expression of SREBP-1 and PPAR\u03b3 is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients","volume":"20","author":"Lemoine","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ando.2011.04.003_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/0003-4819-143-8-200510180-00006","article-title":"Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial","volume":"143","author":"Heine","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2011.04.003_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2515\/therapie:2003022","article-title":"Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatment","volume":"58","author":"G\u00e9rard","year":"2003","journal-title":"Therapie"},{"key":"10.1016\/j.ando.2011.04.003_bib0045","unstructured":"Yeni P, et al. Prise en charge m\u00e9dicale des personnes infect\u00e9es par le VIH en France. Recommandations du groupe d\u2019experts \u2013 Rapport 2010. Minist\u00e8re de la Sant\u00e9 et des Sports."},{"key":"10.1016\/j.ando.2011.04.003_bib0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabet.2010.02.001","article-title":"Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity","volume":"36","author":"Preumont","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ando.2011.04.003_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2334-10-183","article-title":"The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials","volume":"10","author":"Sheth","year":"2010","journal-title":"BMC Infect Dis"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426611000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426611000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:44:53Z","timestamp":1757717093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426611000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0003426611000783"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2011.04.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exenatide improves weight loss insulin sensitivity and \u03b2-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2011.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}